Peijia Medical Ltd. - B: insider trades · Hong Kong · HKEX HKEX:peijia-medical-ltd-b HK HK · HKEX Mcap 3.6Bn€ Healthcare
Discover the full directors' dealings record of Peijia Medical Ltd. - B, a listed issuer based in Hong Kong. Shares are quoted on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Peijia Medical Ltd. - B has logged 20 reports. Market capitalisation: €3.6bn. The latest transaction was filed on 6 May 2026 — Purchase. Among the most active insiders: Ye Hong. All data is accessible without an account.
Financial data FY ended December 2025 · cache
Analyst consensus
5 analysts · 8.49 € Target 9.60 €(+76%) 10.80 €
Income statement
Revenue 712.9 M€
Gross profit 486.1 M€ 68% margin
Net income −203.3 M€ -28.5% margin
Valuation
PER (forward) 37.2x
P/Book 1.7x
Beta 0.56
Balance sheet & cash
Market cap 3.65 Bn€
Total debt 434.0 M€
Free Cash Flow −325.3 M€
Debt / Equity 23%
Profitability & ownership
ROE -10.7%
ROA -4.6%
% insiders 24.8%
% institutions 24.0%
Last declaration on 6 May 2026
Declarations 20 total
Executives ● Purchase7 HKEX
€67,280 100,000 shares @ €0.6728 0.0018% mcap 5.8% of flow
HKEX:DA20260506E00034 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase7 HKEX
€67,280 100,000 shares @ €0.6728 0.0018% mcap 5.8% of flow
HKEX:DA20260506E00036 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase7 HKEX
€67,280 100,000 shares @ €0.6728 0.0018% mcap 5.8% of flow
HKEX:DA20260506E00033 · 30 Apr 2026
Ideal exit: 25 Jan 2027 (T+270) Executives ● Purchase8 HKEX
€223,630 307,000 shares @ €0.7284 0.0061% mcap 19.1% of flow
HKEX:DA20260429E00129 · 24 Apr 2026
Ideal exit: 19 Jan 2027 (T+270) Executives ● Purchase8 HKEX
€223,630 307,000 shares @ €0.7284 0.0061% mcap 19.1% of flow
HKEX:DA20260429E00146 · 24 Apr 2026
Ideal exit: 19 Jan 2027 (T+270) Executives ● Purchase8 HKEX
€223,630 307,000 shares @ €0.7284 0.0061% mcap 19.1% of flow
HKEX:DA20260429E00141 · 24 Apr 2026
Ideal exit: 19 Jan 2027 (T+270) Executives ● Purchase7 HKEX
€65,236 96,000 shares @ €0.6795 0.0018% mcap 5.6% of flow
HKEX:DA20260414E00094 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase7 HKEX
€65,236 96,000 shares @ €0.6795 0.0018% mcap 5.6% of flow
HKEX:DA20260414E00091 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase7 HKEX
€65,236 96,000 shares @ €0.6795 0.0018% mcap 5.6% of flow
HKEX:DA20260414E00088 · 9 Apr 2026
Ideal exit: 4 Jan 2027 (T+270) Executives ● Purchase6 HKEX
33,365 shares
HKEX:DA20260403E00135 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase6 HKEX
33,365 shares
HKEX:DA20260403E00148 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase8 HKEX
€188,303 300,000 shares @ €0.6277 0.0052% mcap 16.1% of flow
HKEX:DA20260403E00117 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase8 HKEX
€188,303 300,000 shares @ €0.6277 0.0052% mcap 16.1% of flow
HKEX:DA20260403E00118 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase8 HKEX
€188,303 300,000 shares @ €0.6277 0.0052% mcap 16.1% of flow
HKEX:DA20260403E00116 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€283,081 424,000 shares @ €0.6676 0.0078% mcap 24.2% of flow
HKEX:DA20260402E00287 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€283,081 424,000 shares @ €0.6676 0.0078% mcap 24.2% of flow
HKEX:DA20260402E00296 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270) Executives ● Purchase9 HKEX
€283,081 424,000 shares @ €0.6676 0.0078% mcap 24.2% of flow
HKEX:DA20260402E00280 · 30 Mar 2026
Ideal exit: 25 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€341,188 506,000 shares @ €0.6743 0.0094% mcap 29.2% of flow
HKEX:DA20260401E00425 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€341,188 506,000 shares @ €0.6743 0.0094% mcap 29.2% of flow
HKEX:DA20260401E00430 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270) Executives ● Purchase10 HKEX
€341,188 506,000 shares @ €0.6743 0.0094% mcap 29.2% of flow
HKEX:DA20260401E00415 · 27 Mar 2026
Ideal exit: 22 Dec 2026 (T+270)